Skip to Main Content

Paper Details

Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.
Neuro Oncol
16
2022
MGMT, MGMT promoter, MPE, MPE-A, MPE-B, Myxopapillary ependymoma, Patients, RNA, extracellular, immune system-related signatures, myxopapillary ependymomas, patients, tumors
Author NameAffiliation
Michael BockmayrUniversity Medical Center Hamburg-Eppendorf
Michael BockmayrResearch Institute Children's Cancer Center Hamburg
Michael BockmayrUniversity Medical Center Hamburg-Eppendorf
Michael BockmayrCharite-Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Institute of Pathology
Leonille SchweizerCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Leonille SchweizerGerman Cancer Research Center (DKFZ)
Abigail K SuwalaInstitute of Pathology, University of Heidelberg
Abigail K Suwala
Abigail K SuwalaClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
David CapperCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
David CapperCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
Stephan FrankInstitute of Medical Genetics and Pathology, University of Basel
Andreas von DeimlingInstitute of Pathology, University of Heidelberg
Stefan RutkowskiUniversity Medical Center Hamburg-Eppendorf
Stefan RutkowskiUniversity Medical Center Hamburg-Eppendorf
Markus GlatzelInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf
Ulrich Sch??llerUniversity Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg
Ulrich Sch??llerInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf
  • 1 - 21

Datasets